Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)

Clinical trial NCT01091792 · COMPLETED

Trial details

NCT number: NCT01091792
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2010-03-01
Primary completion: 2015-04-02
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.